The U.S. Food and Drug Administration has issued emergency use authorization for a screening device that identifies biomarkers that may indicate COVID-19 infection. The Tiger Tech COVID Plus Monitor has already been utilized by homeless shelters, Mt. Sinai Hospital in Miami and on high school sports teams in Las Vegas.Harrison Wittels, Tiger Tech’s Chief Executive Officer, says: “We see this as a possible game-changer for the travel industry. It can be used on cruise ships, transportation hubs, excursions, and even in hotels. We believe our device can play a major role in allowing things to reopen quicker and, most importantly, safer.”For more TPG news delivered each morning to your inbox, sign up for our daily newsletter.How it worksThe Meadows School in Las Vegas where Tiger Tech device is already in use. (Image courtesy Tiger Tech)The Tiger Tech COVID Plus Monitor is an armband equipped with light sensors and a small computer processor. It must be worn for 3-5 minutes, during which biometric abnormalities are checked against COVID patterns. The technology is believed to be so effective that it’s able to identify COVID in asymptomatic individuals.Tiger Tech’s Chief Medical Officer and practicing anesthesiologist Dr. S. Howard Wittels says, “COVID-19 is causing hematological problems in patients…supportive care is being given based on the severity of a patient’s symptoms. For this reason, the sooner you can identify systemic issues, the better the chances are for a positive outcome. We believe our monitor can improve patient care and clinician safety.”Tiger Tech hopes the COVID Plus Monitor will be widely used at schools, airports, corporate offices and on cruise lines to track the spread of COVID and facilitate a return to normalcy.Sign up for our daily newsletterEmail addressSign upI would like to subscribe to The Points Guy newsletters and special email promotions. The Points Guy will not share or sell your email. See privacy policy.Tiger Tech device being used at Miami homeless shelter (Photo courtesy Tiger Tech)The device was tested on over 500 individuals and was deemed 98.6% accurate in correctly identifying positive cases and 94.5% accurate in correctly identifying negative ones.
